Select a Region North America

Insights

Insights From Our Experts

Articles

Excel in Market Access Success: Key Considerations for Leveraging Your Evidence

Introduction The landscape of launching new medical products presents significant challenges, with a staggering 66% of launches falling short of consensus expectations. Half of these failures are attributed directly to poor market access. Recognizing this, companies…

Measuring Willingness to Pay: The Next Access Frontier

EVERSANA’s APAC Team Authors: Robin Arnold, Lakshmi Pragna Kalavacharla, Utkarsh Sahu Patient access to expensive healthcare poses a significant challenge in the pharmaceutical industry. As the cost of developing innovative medicines rises, the demand for accessibility…

Navigating the Patient Journey: Understanding, Challenges, and Solutions in Patient Journey Mapping

EVERSANA’s APAC Authors: Ankit Kulshrestha, Robin Arnold  This POV explores the intricacies of Patient Journey Mapping, detailing its significance, challenges, and solutions. Patient journey mapping is a comprehensive discipline that traces a patient’s entire healthcare journey, from…

Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act

Authors: Chris Cameron, Kerise Clarke, Barkha Patel, Amanda Griffin In anticipation of CMS’s announcement of the first 10 drugs to be selected for negotiations through the Inflation Reduction Act on September 1, 2023, we partnered to…

CES 2024 Recap – How the Future of Healthcare Will Continue to Be Driven By Innovation & AI

CES 2024, the annual tech conference encompassing everything from cutting-edge gadgets to automotive marvels, healthcare innovations, and futuristic media, left a lasting impression. Amidst the buzz surrounding electric vehicles, transparent screens, and an abundance of massage…

Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact

In the dynamic realm of pharmaceutical marketing, sales representatives and television commercials remain go-to strategies, skillfully weaving narratives that assure patients of a brand’s therapeutic benefits and persuade providers to alter prescribing habits. Despite their effectiveness,…

Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival

Author(s): Imtiaz A. Samjoo, MSc, PhD; Emily Rosta, MSc; Austin Lansing, MSc; Alexandra Hall, MPH Despite recent advancements in metastatic prostate cancer (mPC) treatment, prevention and care, progress has not equally manifested in all population groups.…

EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review

A recent independent review conducted by Serret-Larmande and colleagues, featured in the Journal of Clinical Epidemiology, meticulously evaluated population-adjusted indirect comparisons published from 2010-2022. The analysis focused on assessing the reporting quality of methods and results…

Embarking on the Care Journey: Strategies for Engaging Patients Pre- and Post-Diagnosis

Navigating the healthcare system is a complex task for any patient, but it can be particularly tricky for those who are searching for more information on their symptoms, grappling with a recent diagnosis or looking for…

HemGenix Shines in Collaborative ITC Analysis: EVERSANA and CSL Behring Propel Gene Therapy to the Forefront in Hemophilia B Treatment

CSL Behring’s gene therapy for hemophilia B, HemGenix, was evaluated in the HOPE-B Phase III trial versus a basket of conventional FIX replacement products where it was found that the gene therapy reduced the annual bleed…